ProCE Banner Activity

A Look to the Future: Novel Agents and Combination Therapy for Myelofibrosis


This downloadable slideset includes key data on emerging approaches to managing myelofibrosis in the first-line setting and following JAK inhibitor failure or suboptimal response.

Released: May 29, 2024

Expiration: May 28, 2025



Raajit K. Rampal

Raajit K. Rampal, MD, PhD

Associate Member
Director, MPN and Rare Hematologic Malignancies Program
Director, Center for Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner


Supported by an educational grant from GlaxoSmithKline.